Anuh Pharma received reclassification requests from nine promoter group members holding 0.95% total equity to become public shareholders.
The requests cite non-involvement in management and no control over company affairs as rationale for the change.
Board approval and subsequent shareholder and stock exchange approvals are required under SEBI Regulation 31A for completion.
Each promoter provided detailed undertakings confirming they meet all SEBI criteria for reclassification to public category.